CD4+ neoantigens are essential in radiation-induced antitumor immune response, as they not only result in enhanced CD8+ T cell activation and cyto-toxicity, but also engage in direct tumor cell killing through interactions with Fas and the death receptor DR5 on tumor cells (115, 116). Here, FAS is linked to neoplasm.